Abstract:BACKGROUND:Cells derived from lung cancer are biological heterogeneous and have different intrinsic radiosensitivity, it is a key question for us to investigate radiosensitive parameters for an individualized radiotherapy plan. The comet assay is a sensitive and facilitated method to detect single-cell DNA damage and repair, and the results from it have been proven to be so highly coincident with those from clonogenic assay by cell-line investigations that it has been considered as a promising method in predicting radiosensitivity. The study is designed to evaluate preliminarily the correlation between initial DNA damage detected by alkaline comet assay and the clinical endpoints. METHODS:Biopsy samples from 31 lung cancer patients by fibrous bronchial endoscopy were detected by alkaline comet assay from April, 2002 to November, 2002. The adjusted tail moment (R TM) was measured and thoracic local-region lesions were measured by computer tomography scan. Response rate (RR) and time to progression (TTP) for the local-region lesions were as clinical endpoints. SPSS 10.0 software was used to compare median R TM of different RR and TTP groups by Mann-Whitney U and Kruskal-Wallis H rank test, the correlations between R TM with RR and TTP were estimated by Spearman's rank test. RESULTS:There were no statistic differences of median R TM among different pathological types with a median R TM of 0.98, 1.27 and 1.05 in squamous cell carcinoma group, adenocarcinoma group and small cell lung cancer group, respectively (Chi-square=0.347, P=0.84). Through a median follow-up of 10 months, a median R TM of 1.08 and 1.21 for squamous cell carcinoma group and small cell lung cancer group in RR≥50% group was greater than 0.88 and 0.91 in RR < 50% group; median R TM in TTP > 9-monthgroups stratified according to pathological type was greater than that in TTP≤9-month groups (1.26, 1.38 and 1.39 versus 0.71, 0.48 and 1.03 for squamous cell carcinoma group, adenocarcinoma group and small cell lung cancer group respectively), but the differences of R TM classified by RR or TTP were not statistically significant (U=63.5, P=0.58; U=71, P=0.057); the Spearman's coefficients of R TM with RR and TTP were -0.105 (P=0.57) and 0.38 (P=0.035). The coefficients of R TM with TTP was 0.47 for non-small cell lung cancer indicating a modest correlation (P=0.048) and 0.043 for small cell lung cancer (P=0.89). CONCLUSIONS:Although the results are confounded due to sampling and the greater background tail moments, Spearman's coefficient of R TM with TTP for non-small cell lung cancer indicates a modest positive correlation. The comet assay might be a promising method in predicting intrinsic radiosensitivity of lung cancer cells and techniques for sampling and assaying need to be further improved.

[Detecting DNA Repair Capacity of Human Lymphocytes Exposed to Ultraviolet C with Comet Assay].

Assessment of Human DNA Repair (NER) Capacity with DNA Repair Rate (DRR) by Comet Assay.

Evaluating the Combinative Effects on Human Lymphocyte DNA Damage Induced by Ultraviolet Ray C Plus 1.8ghz Microwaves Using Comet Assay in Vitro

Detecting DNA Repair Capacity of Peripheral Lymphocytes from Cancer Patients with UVC Challenge Test and Bleomycin Challenge Test

DNA Damage Induced by UV in K562 Cells Measured by Comet Assay

DNA repair as a human biomonitoring tool: Comet assay approaches

Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay.

[Correlation of Initial DNA Damage Detected by Alkaline Comet Assay and Clinical Endpoints in Lung Cancer Patients].

The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations

Influence of 1.8-GHz (GSM) radiofrequency radiation (RFR) on DNA damage and repair induced by X-rays in human leukocytes in vitro.

Gamma-radiation-induced Single Cell DNA Damage As a Measure of Susceptibility to Lung Cancer: a Preliminary Report.

Effect of cryopreservation on DNA damage and DNA repair activity in human blood samples in the comet assay

Impact of 1.8-GHz radiofrequency radiation (RFR) on DNA damage and repair induced by doxorubicin in human B-cell lymphoblastoid cells

The comet assay: a method to measure DNA damage in individual cells

The DNA Damage and Repair of High Doses of X-Ray on Human Peripheral Blood Nucreated Cells

Alkaline Comet Assay for Assessing DNA Damage in Individual Cells

The comet assay: what can it really tell us?

An optimized comet-based in vitro DNA repair assay to assess base and nucleotide excision repair activity

DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers

The comet assay: topical issues

The DNA Damage of High Doses of X-ray on Human Peripheral Blood Nucleated Cell's and Sperm